Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07822906 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Risk of Esophageal Cancer Returning After Immunotherapy, Chemotherapy, and Surgery

StatusNot Yet Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Minor Study First Submitted
This observational study aims to understand the risk of cancer returning after surgery in people with esophageal squamous cell carcinoma, a type of cancer of the food pipe. It focuses on people who received immunotherapy and chemotherapy before surgery. Researchers will review existing medical records, scans, reports on tissue removed during surgery, and follow-up information. They will examine when and where cancer returns and which patient characteristics, treatment details, scan findings, and tissue findings are associated with its return. All treatment and tests were part of routine care. The study does not assign treatment or require additional scans, tissue collection, or follow-up visits.
Trial Details
NCT Number NCT07822906
Lead Sponsor Peking University Cancer Hospital & Institute
Conditions
(from sponsor)
Esophageal Squamous Cell Carcinoma (ESCC)
Related terms Esophageal Squamous Cell Carcinoma, Lymphatic Metastasis
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov